🇺🇸 FDA
Patent

US 7560105

Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses

granted A61KA61K2035/122A61K40/19

Quick answer

US patent 7560105 (Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses) held by Leids Universitair Medisch Centrum expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Leids Universitair Medisch Centrum
Grant date
Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
43
CPC classes
A61K, A61K2035/122, A61K40/19, A61K40/24, A61K40/4215